2019 Boehringer Ingelheim Innovation Prize in San Diego

Event Information

Share this event

Date and Time



BioLabs San Diego

9620 Towne Centre Dr

Suite 100

San Diego, California 92121

View Map

Event description


Apply Now For the BI Innovation Prize! Winner receives a Golden Ticket to BioLabs

Valued at $75,000, the winner, who will be announced during a Networking Reception that evening, will receive Boehringer Ingelheim’s ‘Golden Ticket’ – a voucher which represents prepaid rent for one reserved bench in BioLabs’ shared laboratory space in University Towne Centre for one year. Boehringer Ingelheim receives this ‘Golden Ticket’ as part of its sponsorship of the BioLabs facility.

Shortlisted applicants will be invited to present their ideas in a poster session at BioLabs, San Diego, on February 28th 2019, from which a final short-list is selected to pitch their ideas to a panel of judges.

Entry Requirements

Early-stage innovators and spin-outs that are pursuing life-science therapeutic platform technologies and therapeutics (in any indication, any modality) are invited to participate. Diagnostics, Instrument development, and Health-IT are excluded.
Companies must be founded and have their principle place of business in California
Companies must not have a major partnership with another large bio-pharmaceutical company
Companies must be focused on new target concepts or drug discovery

How to Apply

Applicants must provide a non-confidential deck of no more than ten slides. Slides must address unmet medical need, solution, scientific principal, key data supporting the scientific principal, overview of business case, and intellectual property.


SUBMIT YOUR APPLICATION HERE (If you are submitting a prize entry, please register for the networking reception below)

BI Innovation Prize Networking Reception


5:00 pm - Arrival and Registration

5:30pm - Networking

6:15pm - BI Academy - Thinking with the end in mind: reimbursement, pricing and business models

7:15pm - Innovation Prize

  • 3rd Round Advancement

  • Judging

  • Award Ceremony

8:30pm - Conclusion

Thinking with the end in mind: reimbursement, pricing and business models

Early stage companies (and investors) focus almost to their detriment on getting to scientific and business inflection points , without a clear understanding on whether or not they will get reimbursed on their products. Reimbursement informs the business model and is a major driver in understanding business valuation.

When it comes to building value for early stage companies, understanding your business model is key. How you make money, how much your product will cost, and how you will price your therapy or diagnostic goes to understanding the value of your company, and the value of your product (s).

A cornerstone to developing your business plan, will be to have a reimbursement plan that anticipates opportunities and obstacles and strategies to manage possible pitfalls. "Approaching reimbursement proactively can have a positive impact both during the early stages of product development and well after product launch. Many companies analyze reimbursement as part of the early business-planning process to identify economically attractive indications and market opportunities."

Join us for what promises to be a very interesting and informative discussion on building your company by thinking with the end in mind.

Moderated by: Imran Nasrullah, Director, Strategic Partnering, BD&L at Boehringer Ingelheim


  • Erin Mistry, Managing Director of Syneos Health

  • John Hood, Ph.D., CEO of Actavalon

  • David Armstrong, Field Team Director for BI HEOR

  • Carol Gallagher, Partner, New Enterprise Associates

Share with friends

Date and Time


BioLabs San Diego

9620 Towne Centre Dr

Suite 100

San Diego, California 92121

View Map

Save This Event

Event Saved